| Literature DB >> 20144298 |
Stefano Ferri1, Seungsu Kim, Wakako Tsugawa, Koji Sode.
Abstract
Glycated proteins, particularly glycated hemoglobin A1c, are important markers for assessing the effectiveness of diabetes treatment. Convenient and reproducible assay systems based on the enzyme fructosyl amino acid oxidase (FAOD) have become attractive alternatives to conventional detection methods. We review the available FAOD-based assays for measurement of glycated proteins as well as the recent advances and future direction of FAOD research. Future research is expected to lead to the next generation of convenient, simple, and economical sensors for glycated protein, ideally suited for point-of-care treatment and self-monitoring applications. 2009 Diabetes Technology Society.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20144298 PMCID: PMC2769878 DOI: 10.1177/193229680900300324
Source DB: PubMed Journal: J Diabetes Sci Technol ISSN: 1932-2968